106 related articles for article (PubMed ID: 27670669)
1. (±)-Gossypol induces apoptosis and autophagy in head and neck carcinoma cell lines and inhibits the growth of transplanted salivary gland cancer cells in BALB/c mice.
Benvenuto M; Mattera R; Masuelli L; Taffera G; Andracchio O; Tresoldi I; Lido P; Giganti MG; Godos J; Modesti A; Bei R
Int J Food Sci Nutr; 2017 May; 68(3):298-312. PubMed ID: 27670669
[TBL] [Abstract][Full Text] [Related]
2. Violacein, an indole-derived purple-colored natural pigment produced by Janthinobacterium lividum, inhibits the growth of head and neck carcinoma cell lines both in vitro and in vivo.
Masuelli L; Pantanella F; La Regina G; Benvenuto M; Fantini M; Mattera R; Di Stefano E; Mattei M; Silvestri R; Schippa S; Manzari V; Modesti A; Bei R
Tumour Biol; 2016 Mar; 37(3):3705-17. PubMed ID: 26462840
[TBL] [Abstract][Full Text] [Related]
3. In vitro effects of the BH3 mimetic, (-)-gossypol, on head and neck squamous cell carcinoma cells.
Oliver CL; Bauer JA; Wolter KG; Ubell ML; Narayan A; O'Connell KM; Fisher SG; Wang S; Wu X; Ji M; Carey TE; Bradford CR
Clin Cancer Res; 2004 Nov; 10(22):7757-63. PubMed ID: 15570010
[TBL] [Abstract][Full Text] [Related]
4. The BH3-mimetic gossypol and noncytotoxic doses of valproic acid induce apoptosis by suppressing cyclin-A2/Akt/FOXO3a signaling.
Zhao GX; Xu LH; Pan H; Lin QR; Huang MY; Cai JY; Ouyang DY; He XH
Oncotarget; 2015 Nov; 6(36):38952-66. PubMed ID: 26517515
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis and antitumor effects of a small molecule inhibitor of Bcl-2 and Bcl-xl, gossypol acetate, in multiple myeloma in vitro and in vivo.
Lin J; Wu Y; Yang D; Zhao Y
Oncol Rep; 2013 Aug; 30(2):731-8. PubMed ID: 23708869
[TBL] [Abstract][Full Text] [Related]
6. Gossypol reduction of tumor growth through ROS-dependent mitochondria pathway in human colorectal carcinoma cells.
Ko CH; Shen SC; Yang LY; Lin CW; Chen YC
Int J Cancer; 2007 Oct; 121(8):1670-9. PubMed ID: 17597109
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro inhibition of osteosarcoma growth by the pan Bcl-2 inhibitor AT-101.
Masuelli L; Benvenuto M; Izzi V; Zago E; Mattera R; Cerbelli B; Potenza V; Fazi S; Ciuffa S; Tresoldi I; Lucarelli E; Modesti A; Bei R
Invest New Drugs; 2020 Jun; 38(3):675-689. PubMed ID: 31264066
[TBL] [Abstract][Full Text] [Related]
8. The PPARγ agonist rosiglitazone sensitizes the BH3 mimetic (-)-gossypol to induce apoptosis in cancer cells with high level of Bcl-2.
Li X; He J; Li B; Gao M; Zeng Y; Lian J; Shi C; Huang Y; He F
Mol Carcinog; 2018 Sep; 57(9):1213-1222. PubMed ID: 29856104
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol potentiates the in vitro and in vivo anti-tumoral effects of curcumin in head and neck carcinomas.
Masuelli L; Di Stefano E; Fantini M; Mattera R; Benvenuto M; Marzocchella L; Sacchetti P; Focaccetti C; Bernardini R; Tresoldi I; Izzi V; Mattei M; Frajese GV; Lista F; Modesti A; Bei R
Oncotarget; 2014 Nov; 5(21):10745-62. PubMed ID: 25296980
[TBL] [Abstract][Full Text] [Related]
10. A novel BH3 mimetic efficiently induces apoptosis in melanoma cells through direct binding to anti-apoptotic Bcl-2 family proteins, including phosphorylated Mcl-1.
Liu Y; Xie M; Song T; Sheng H; Yu X; Zhang Z
Pigment Cell Melanoma Res; 2015 Mar; 28(2):161-70. PubMed ID: 25324174
[TBL] [Abstract][Full Text] [Related]
11. (-)-Gossypol suppresses the growth of human prostate cancer xenografts via modulating VEGF signaling-mediated angiogenesis.
Pang X; Wu Y; Wu Y; Lu B; Chen J; Wang J; Yi Z; Qu W; Liu M
Mol Cancer Ther; 2011 May; 10(5):795-805. PubMed ID: 21372225
[TBL] [Abstract][Full Text] [Related]
12. Reversal of cisplatin resistance with a BH3 mimetic, (-)-gossypol, in head and neck cancer cells: role of wild-type p53 and Bcl-xL.
Bauer JA; Trask DK; Kumar B; Los G; Castro J; Lee JS; Chen J; Wang S; Bradford CR; Carey TE
Mol Cancer Ther; 2005 Jul; 4(7):1096-104. PubMed ID: 16020667
[TBL] [Abstract][Full Text] [Related]
13. RITA plus 3-MA overcomes chemoresistance of head and neck cancer cells via dual inhibition of autophagy and antioxidant systems.
Shin D; Kim EH; Lee J; Roh JL
Redox Biol; 2017 Oct; 13():219-227. PubMed ID: 28582730
[TBL] [Abstract][Full Text] [Related]
14. Gossypol induces apoptosis in multiple myeloma cells by inhibition of interleukin-6 signaling and Bcl-2/Mcl-1 pathway.
Sadahira K; Sagawa M; Nakazato T; Uchida H; Ikeda Y; Okamoto S; Nakajima H; Kizaki M
Int J Oncol; 2014 Dec; 45(6):2278-86. PubMed ID: 25231749
[TBL] [Abstract][Full Text] [Related]
15. Iressa induces cytostasis and augments Fas-mediated apoptosis in acinic cell adenocarcinoma overexpressing HER2/neu.
Piechocki MP; Yoo GH; Dibbley SK; Amjad EH; Lonardo F
Int J Cancer; 2006 Jul; 119(2):441-54. PubMed ID: 16470840
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral delivery of recombinant vaccinia virus encoding for ErbB2/Neu inhibits the growth of salivary gland carcinoma cells.
Masuelli L; Fantini M; Benvenuto M; Sacchetti P; Giganti MG; Tresoldi I; Lido P; Lista F; Cavallo F; Nanni P; Schlom J; Modesti A; Bei R
J Transl Med; 2014 May; 12():122. PubMed ID: 24886178
[TBL] [Abstract][Full Text] [Related]
17. ApoG2 as the most potent gossypol derivatives inhibits cell growth and induces apoptosis on gastric cancer cells.
Xin J; Zhan YH; Xia LM; Zhu HW; Nie YZ; Liang JM; Tian J
Biomed Pharmacother; 2013 Feb; 67(1):88-95. PubMed ID: 23201009
[TBL] [Abstract][Full Text] [Related]
18. Synergistic combination of small molecule inhibitor and RNA interference against antiapoptotic Bcl-2 protein in head and neck cancer cells.
Lin YL; Yuksel Durmaz Y; Nör JE; ElSayed ME
Mol Pharm; 2013 Jul; 10(7):2730-8. PubMed ID: 23734725
[TBL] [Abstract][Full Text] [Related]
19. Proteasome inhibition by bortezomib parallels a reduction in head and neck cancer cells growth, and an increase in tumor-infiltrating immune cells.
Benvenuto M; Ciuffa S; Focaccetti C; Sbardella D; Fazi S; Scimeca M; Tundo GR; Barillari G; Segni M; Bonanno E; Manzari V; Modesti A; Masuelli L; Coletta M; Bei R
Sci Rep; 2021 Sep; 11(1):19051. PubMed ID: 34561494
[TBL] [Abstract][Full Text] [Related]
20. Anticancer effects of putative and validated BH3-mimetic drugs in head and neck squamous cell carcinomas: An overview of current knowledge.
Melo G; Silva CAB; Hague A; Parkinson EK; Rivero ERC
Oral Oncol; 2022 Sep; 132():105979. PubMed ID: 35816876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
